Reducing pain after breast reduction surgery with a surgeon-guided block
Postoperative Analgesic Efficacy of Intraoperative Surgeon-Guided Serratus Block: A Prospective Randomized Study
This study tests if a special pain relief technique used during breast reduction surgery can help women feel less pain afterward and use less medication.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Samsun University Academic / other |
| Locations | 1 site (Samsun) |
| Trial ID | NCT06905574 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a surgeon-guided serratus block in reducing postoperative pain for women undergoing breast reduction surgery. The intervention aims to minimize pain sensation in the surgical area, potentially leading to lower analgesic consumption and fewer complications in the first 24 hours post-surgery. Participants will be monitored for their pain levels and medication use following the procedure to assess the block's effectiveness.
Who should consider this trial
Good fit: Ideal candidates are women aged 18-65 undergoing inferior pedicled breast reduction surgery with specific anatomical criteria.
Not a fit: Patients with a history of malignancy, severe organ failure, or those who refuse participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance postoperative comfort and recovery for patients undergoing breast reduction.
How similar studies have performed: While similar approaches have been explored, this specific application of the serratus block in breast reduction surgery is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient's willingness to be included in the study * 18-65 years * Woman * Operated with inferior pedicled breast reduction technique * The distance from the sternal notch to the nipple complex is between 25-40cm * ASA I-II * Breast Usg result BIRADS 1-2 * Patients who have not previously received RT to the breast and have no history of malignancy Exclusion Criteria: * Patient's request/refusal not to be included in the study * Previous history of malignancy * RT story, * ASA 3-4-5-patient group * Severe organ failure * Alcohol, drug addiction * Bupivacaine allergy * Diagnosis of psychiatric illness and psychiatric drug use * Surgery lasting longer than 3 hours * Bleeding diathesis
Where this trial is running
Samsun
- Samsun training and research hospital — Samsun, Turkey (Recruiting)
Study contacts
- Study coordinator: Ayhan Sönmez
- Email: sonmezayhan19@gmail.com
- Phone: +905062775944
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.